U.S. Emerging Transdermal Drug Delivery Technologies Markets


USD 2,450.00

* Required Fields

USD 2,450.00


Be the first to review this product

This report analyzes the U.S. emerging transdermal drug delivery technologies markets, for the forecast period 1999 to 2009. The report is segmented into 5 chapters viz. Executive Summary, Total Market, Passive Patches Market, Transdermal Gel Products Market and Active Transdermal Systems Market. Each segment provides revenue forecasts, market share, pricing trends, demand analysis, competitive structure and market and technology trends. Drivers, restraints and challenges are also discussed. The Market Engineering Awards are conferred on deserving companies.

Table of Contents

U.S. Emerging Transdermal Drug Delivery Technologies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Emerging Transdermal Drug Delivery Technologies Markets, Total MarketOverviewIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsForecasts and TrendsDemand AnalysisRevenue ForecastsChallengesLimited Applications Impede Market Expansion and GrowthDelay in Launch of Improved Products Impedes Market ExpansionCompeting Technologies Limit Market PotentialDawdling Acceptance Constrains Market ProgressDubious Fate of Emerging Technologies Limits AggressionAwardsProduct Differentiation Innovation Strategy AwardTechnology Leadership AwardMarket Leadership AwardMarket Penetration Strategy AwardProduct Positioning and Market Expansion Strategy AwardU.S. Emerging Transdermal Drug Delivery Technologies Markets, Passive Transdermal Patches MarketOverviewIntroductionMarket Engineering AnalysisForecasts and TrendsPrescription AnalysisPricing AnalysisRevenue ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisU.S. Emerging Transdermal Drug Delivery Technologies Markets, Transdermal Gel Products Market Overview and ForecastsIntroductionMarket Engineering AnalysisForecastsCompetitive AnalysisUnimed PharmaceuticalsAuxilium PharmaceuticalsCellegy PharmaceuticalsBioSante PharmaceuticalsNovavaxU.S. Emerging Transdermal Drug Delivery Technologies Markets, Active Transdermal Products MarketOverview and ForecastsIntroductionMarket Engineering AnalysisForecastsCompetitive AnalysisAlzaAltea TherapeuticsSontra Medical CorporationBirch Point MedicalVyterisGenetronics

Related Research

Release Date : 21-Nov-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.